176655-56-4 (利托那韦杂质E,Hydroxy Ritonavir)

雷托那韦杂质E;利托那韦杂质E;

Hydroxy Ritonavir;1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-2-[[[2-(2-hydroxypropan-2-yl)-1,3-thiazol-4-yl]methyl-methylcarbamoyl]amino]-3-methylbutanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate;RITONAVIR HYDROXY METABOLITE;Ritonavir IMpurity E (Hydroxy Ritonavir);[5S-(5R*,8R*,10R*,11R*)]-10-Hydroxy-1-[2-(1-hydroxy-1-Methylethyl)-4-thiazolyl]-2-Methyl-5-(1-Methylethyl)-3,6-dioxo-8,11-bis(phenylMethyl)-;RITONAVIR IMPURITY, HYDROXYRITONAVIR- [USP IMPURITY];JN1D7K606N;RITONAVIR IMPURITY E [EP IMPURITY];Thiazol-5-ylmethyl ((1S,2S,4S)-1-benzyl-2-hydroxy-4-(((2S)-2-((((2-(1-hydroxy-1-methylethyl)thiazol-4-yl)methyl)methylcarbamoyl)amino)-3-methylbutanoyl)amino)-5-phenylpentyl)carbamate;Thiazol-5-ylmethyl ((2S,3S,5S)-3-hydroxy-5-((S)-2-(3-((2-(2-hydroxypropan-2-yl)thiazol-4-yl)methyl)-3-methylureido)-3-methylbutanamido)-1,6-diphenylhexan-2-yl)carbamate;CHEMBL3544628;Ritonavir impurity, hydroxyritonavir- [USP];CS-0140457;F82775;UNII-JN1D7K606N;2,7,10,12-Tetraazatridecanoic acid, 4-hydroxy-13-(2-(1-hydroxy-1-methylethyl)-4-thiazolyl)-12-methyl-9-(1-methylethyl)-8,11-dioxo-3,6-bis(phenylmethyl)-, 5-thiazolylmethyl ester, (3S,4S,6S,9S)-;Q27281586;J-011211;176655-56-4;starbld0024018;MS-31280;DTXSID10170167;Ritonavir specified impurity E [EP];RITONAVIR METABOLITE M2;HY-137565;Hydroxyritonavir;CHEBI:172813;

CLEDZMPJHBBTNZ-QJANCWQKSA-N

1S/C37H48N6O6S2/c1-24(2)32(42-35(46)43(5)20-28-22-50-34(40-28)37(3,4)48)33(45)39-27(16-25-12-8-6-9-13-25)18-31(44)30(17-26-14-10-7-11-15-26)41-36(47)49-21-29-19-38-23-51-29/h6-15,19,22-24,27,30-32,44,48H,16-18,20-21H2,1-5H3,(H,39,45)(H,41,47)(H,42,46)/t27-,30-,31-,32-/m0/s1

S1C=C(CN(C)C(N[C@H](C(N[C@@H](CC2C=CC=CC=2)C[C@@H]([C@H](CC2C=CC=CC=2)NC(=O)OCC2=CN=CS2)O)=O)C(C)C)=O)N=C1C(C)(C)O